Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cimpress (CMPR) Cash & Equivalents (2016 - 2025)

Cimpress (CMPR) has 17 years of Cash & Equivalents data on record, last reported at $258.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 14.98% year-over-year to $258.0 million; the TTM value through Dec 2025 reached $258.0 million, up 14.98%, while the annual FY2025 figure was $234.0 million, 14.82% up from the prior year.
  • Cash & Equivalents reached $258.0 million in Q4 2025 per CMPR's latest filing, up from $200.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $277.1 million in Q2 2022 and bottomed at $36.4 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $179.1 million, with a median of $183.0 million recorded in 2021.
  • The widest YoY moves for Cash & Equivalents: up 526.74% in 2021, down 84.07% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $231.2 million in 2021, then tumbled by 51.86% to $111.3 million in 2022, then skyrocketed by 146.41% to $274.2 million in 2023, then fell by 18.15% to $224.4 million in 2024, then grew by 14.98% to $258.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $258.0 million in Q4 2025, $200.5 million in Q3 2025, and $234.0 million in Q2 2025.